GlassScriptPhysician profile
Mathew T Gill
NPI 1376754200
$4,391.54
in general payments reported to CMS, 2019-2025
17 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.00 · 2020: $40.66 · 2021: $353 · 2022: $377 · 2023: $620 · 2024: $2,281 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,176 · Travel and Lodging: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.77 |
| Travel and Lodging | $1,359.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,821.55 | 2024 | Coblation, Tula |
| Aerin Medical INC. | $661.24 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $462.74 | 2019-2025 | Dupixent |
| Medtronic, INC. | $369.27 | 2021-2025 | Stealthstation S8 Platform, Sinuva |
| Genzyme Corporation | $255.79 | 2023-2024 | |
| Optinose US, INC. | $222.46 | 2021-2025 | |
| Intersect Ent, INC. | $163.86 | 2021-2022 | |
| Glaxosmithkline, LLC. | $139.28 | 2022-2025 | Nucala |
| Alk-Abello, INC | $82.19 | 2019-2023 | Ragwitek, Odactra, Grastek |
| Ars Pharmaceuticals Operations, INC. | $45.81 | 2025 | Neffy |
| Stryker Corporation | $33.30 | 2022 | |
| Paratek Pharmaceuticals, INC. | $33.26 | 2025 | Xhance |
| Alcon Vision LLC | $27.25 | 2020 | |
| Merck Sharp & Dohme LLC | $21.83 | 2023 | |
| Novartis Pharmaceuticals Corporation | $19.99 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $18.27 | 2023 | Fetroja |
| Arbor Pharmaceuticals, INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.